OAM
RARE icon

Oxford Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Oxford Asset Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,475
Closed -$471K – 679
2025
Q4 		$471K Buy
+20,475
New +$673K 0.17% 195
2025
Q2 		– Sell
-8,421
Closed -$305K – 723
2025
Q1 		$305K Buy
+8,421
New +$350K 0.14% 252
2019
Q2 		– Sell
-3,101
Closed -$215K – 1916
2019
Q1 		$215K Buy
+3,101
New +$177K ﹤0.01% 1493
2018
Q3 		– Sell
-8,152
Closed -$621K – 1886
2018
Q2 		$621K Buy
8,152
+4,143
+103% +$268K 0.01% 1257
2018
Q1 		$204K Buy
+4,009
New +$202K ﹤0.01% 1484
2016
Q1 		– Sell
-28,031
Closed -$3.17M – 878
2015
Q4 		$3.17M Buy
+28,031
New +$2.8M 0.07% 293

Other funds holding RARE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return